Welcome to The mRNA Monthly: Your trusted source for insight, innovation, and updates from the world of mRNA therapeutics.
Each month, we bring together the most relevant breakthroughs, trends, and real-world challenges shaping the future of mRNA and LNP-based medicines. Whether you’re advancing early research, scaling up for clinical trials, or navigating regulatory pathways, The mRNA Monthly delivers expert perspectives and practical knowledge from across the biotech landscape.
You’ll find thought leadership from Vernal’s scientific team, case studies, curated news, commentary on industry developments, and strategic insights into analytics, manufacturing, and mRNA delivery. Follow along to stay informed—and inspired—as we explore what’s next in mRNA innovation.
The mRNA Monthly—July 2025 Edition
Research‑Grade mRNA That Moves as Fast as Your Ideas Learn more about key considerations when sourcing research-grade mRNA and discover Vernal’s approach to its new research-grade mRNA…
The mRNA Monthly—June 2025 Edition
Advancements in Biopharma Spur Innovation Christian Cobaugh, chief scientific officer and founder of Vernal Biosciences, offered PharmaTech editor Susan Haigney comments about where he believes mRNA and…
The mRNA Monthly—May 2025 Edition
Awakening the Giant: The Next Frontier in mRNA Therapeutics We’ve seen what mRNA can do in vaccines—but that was only the beginning. In a new article published…
The mRNA Monthly—April 2025 Edition
The Evolving Needs of Therapeutic mRNA Developers Insights on the next wave of challenges mRNA innovators face as an increasing number of therapeutics move through the pipeline….